Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets
Nina Bhardwaj, Philip Friedlander, Anna C. Pavlick, Marc S. Ernstoff, Brian Gastman, Brent A. Hanks, Brendan D. Curti, Mark R. Albertini, Jason J. Luke, Ana-Belén Blázquez, Sreekumar Balan, Davide Bedognetti, Joseph Beechem, Andrea Crocker, Leonard D’Amico, Patrick Danaher, Thomas A. Davis, Thomas Hawthorne, Bruce W. Hess, Tibor Keler, Lisa Lundgren, Chihiro Morishima, Nirasha Ramchurren, Darawan Rinchai, Andres Μ. Salazar, Bob Salim, Elad Sharon, Laura Vitale, Ena Wang, Sarah Warren, Michael Yellin, Mary L. Disis, Martin A. Cheever, Steven P. Fling
Topics & Concepts
Dendritic cellImmune systemImmunologyTLR3TLR7AntigenImmunotherapyMedicineBiologyInnate immune systemCancer researchToll-like receptorImmunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkersvaccines and immunoinformatics approaches